Systemic contact dermatitis from Orinase and Diabinese in diabetics with para-amino hypersensitivity

Diabetic patients sensitized by topical medication containing such para-amino compounds as sulfanilamide and benzocaine can acquire a widespread eczematous "systemic" contact dermatitis from the oral administration of such para-amino hypoglycemic drugs as Orinase or Diabinese.